Hua Zhang1, Jian Wu, Lin Meng, Cheng-Chao Shou. 1. Department of Biochemistry and Molecular Biology, Peking University School of Oncology, Beijing Institute for Cancer Research, China.
Abstract
AIM: The expression of vascular endothelial growth factor (VEGF) and its receptors KDR and Flt-1 by gastric carcinoma tissues and different gastric carcinoma cell lines was detected to elucidate the molecular mechanism of this growth factor in promoting tumor growth. METHODS: The expression of VEGF, Flt-1 and KDR was determined by reverse transcription-polymerase chain reaction (RT-PCR) in gastric cancer cell lines RF-1, RF-48, AGS-1, NCI-N87, NCI-SNU-1, NCI-SNU-5, NCI-SNU-16 and KATO-III. The expression of Flt-1 and KDR in paraffin-embedded specimens of gastric cancer was determined by immunohistochemistry. The 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay was used to assess the role of VEGF in tumor cell proliferation. RESULTS: All 8 gastric cancer cell lines analyzed expressed VEGF(121) and VEGF(165) and six of them expressed both Flt-1 and KDR, while cell line NCI-SNU-5 expressed Flt-1 only and cell line KATOIII expressed neither Flt-1 nor KDR. The gastric carcinoma tissues expressed Flt-1 and KDR widely, with the positive rate of expression of Flt-1 and KDR being 84.6 % and 70 % respectively. The exogenous VEGF stimulated the growth of KDR-positive cell lines NCI-N87 and AGS-1 in a dose-dependent manner but exhibited no effect on the growth of KDR-negative cell line NCI-N87. CONCLUSION: VEGF and its receptors KDR and Flt-1 were expressed widely in gastric carcinoma cells and the VEGF stimulated KDR-positive tumor cell growth directly. These results suggest that VEGF may play a role in promoting tumor growth and metastasis by participating in both paracrine and autocrine pathways.
AIM: The expression of vascular endothelial growth factor (VEGF) and its receptors KDR and Flt-1 by gastric carcinoma tissues and different gastric carcinoma cell lines was detected to elucidate the molecular mechanism of this growth factor in promoting tumor growth. METHODS: The expression of VEGF, Flt-1 and KDR was determined by reverse transcription-polymerase chain reaction (RT-PCR) in gastric cancer cell lines RF-1, RF-48, AGS-1, NCI-N87, NCI-SNU-1, NCI-SNU-5, NCI-SNU-16 and KATO-III. The expression of Flt-1 and KDR in paraffin-embedded specimens of gastric cancer was determined by immunohistochemistry. The 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay was used to assess the role of VEGF in tumor cell proliferation. RESULTS: All 8 gastric cancer cell lines analyzed expressed VEGF(121) and VEGF(165) and six of them expressed both Flt-1 and KDR, while cell line NCI-SNU-5 expressed Flt-1 only and cell line KATOIII expressed neither Flt-1 nor KDR. The gastric carcinoma tissues expressed Flt-1 and KDR widely, with the positive rate of expression of Flt-1 and KDR being 84.6 % and 70 % respectively. The exogenous VEGF stimulated the growth of KDR-positive cell lines NCI-N87 and AGS-1 in a dose-dependent manner but exhibited no effect on the growth of KDR-negative cell line NCI-N87. CONCLUSION:VEGF and its receptors KDR and Flt-1 were expressed widely in gastric carcinoma cells and the VEGF stimulated KDR-positive tumor cell growth directly. These results suggest that VEGF may play a role in promoting tumor growth and metastasis by participating in both paracrine and autocrine pathways.
Authors: Z von Marschall; T Cramer; M Höcker; R Burde; T Plath; M Schirner; R Heidenreich; G Breier; E O Riecken; B Wiedenmann; S Rosewicz Journal: Gastroenterology Date: 2000-11 Impact factor: 22.682
Authors: S Folli; P Morgagni; F Roviello; G De Manzoni; D Marrelli; L Saragoni; A Di Leo; M Gaudio; O Nanni; A Carli; C Cordiano; D Dell'Amore; A Vio Journal: Jpn J Clin Oncol Date: 2001-10 Impact factor: 3.019
Authors: M Takahama; M Tsutsumi; T Tsujiuchi; A Kido; H Sakitani; K Iki; S Taniguchi; S Kitamura; Y Konishi Journal: Mol Carcinog Date: 1999-04 Impact factor: 4.784
Authors: C Gómez-Martín; R Salazar; C Montagut; M Gil-Martín; J A Núñez; M Puig; X Lin; R Khosravan; J M Tursi; M J Lechuga; J Bellmunt Journal: Invest New Drugs Date: 2012-05-22 Impact factor: 3.850
Authors: K-W Lee; S R Park; D-Y Oh; Y-I Park; R Khosravan; X Lin; S-Y Lee; E-J Roh; O Valota; M J Lechuga; Y-J Bang Journal: Invest New Drugs Date: 2013-10-04 Impact factor: 3.850